Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of VC005 Tablets in Healthy Adult Subjects
NCT07533851Phase 1Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of VC-005 in atopic dermatitis (AD) (2 arms), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration and Area under the plasma concentration-time curve. Started Apr 2026; status: completed.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07533851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07533851.